Shoulder Innovations, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US82537J1088
USD
18.76
0.87 (4.86%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

43.37 k

Shareholding (Mar 2026)

FII

3.91%

Held by 14 FIIs

DII

92.90%

Held by 17 DIIs

Promoter

3.18%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 286 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.78

stock-summary
Return on Equity

-999,999.00%

stock-summary
Price to Book

2.03

Revenue and Profits:
Net Sales:
17 Million
(Quarterly Results - Mar 2026)
Net Profit:
-8 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
33.9%
0%
33.9%
6 Months
25.57%
0%
25.57%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Shoulder Innovations, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
56.70%
EBIT Growth (5y)
-164.94%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
41.50%
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.03
EV to EBIT
-6.72
EV to EBITDA
-7.66
EV to Capital Employed
5.63
EV to Sales
3.74
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-83.70%
ROE (Latest)
-19.60%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
Bollinger Bands
Bullish
KST
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 13 Schemes (15.7%)

Foreign Institutions

Held by 14 Foreign Institutions (3.91%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 15.97% vs 22.03% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -7.69% vs 10.34% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "16.70",
          "val2": "14.40",
          "chgp": "15.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-7.80",
          "val2": "-7.50",
          "chgp": "-4.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-8.40",
          "val2": "-7.80",
          "chgp": "-7.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-537.20%",
          "val2": "-589.60%",
          "chgp": "5.24%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 49.68% vs 63.73% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -158.97% vs -22.83% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "47.30",
          "val2": "31.60",
          "chgp": "49.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-23.10",
          "val2": "-12.50",
          "chgp": "-84.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "1.30",
          "chgp": "-92.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-14.20",
          "val2": "-0.10",
          "chgp": "-14,100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-40.40",
          "val2": "-15.60",
          "chgp": "-158.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-555.80%",
          "val2": "-463.40%",
          "chgp": "-9.24%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQstock-summary

Mar'26
Dec'25
Change(%)
Net Sales
16.70
14.40
15.97%
Operating Profit (PBDIT) excl Other Income
-7.80
-7.50
-4.00%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-8.40
-7.80
-7.69%
Operating Profit Margin (Excl OI)
-537.20%
-589.60%
5.24%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2026 is 15.97% vs 22.03% in Dec 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -7.69% vs 10.34% in Dec 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
47.30
31.60
49.68%
Operating Profit (PBDIT) excl Other Income
-23.10
-12.50
-84.80%
Interest
0.10
1.30
-92.31%
Exceptional Items
-14.20
-0.10
-14,100.00%
Consolidate Net Profit
-40.40
-15.60
-158.97%
Operating Profit Margin (Excl OI)
-555.80%
-463.40%
-9.24%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 49.68% vs 63.73% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -158.97% vs -22.83% in Dec 2024

stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details